Sharp Clinical Launches Direct-to-Patient Service with New Partnerships
Sharp Clinical Services has signed a central pharmacy partnership deal and developed a holistic patient support program with its sister company, Ashfield. Sharp has also signed a partnership agreement with European central pharmacy Hubertus, Germany, which will support Sharp’s direct-to-patient logistics service for its clinical trial clients in Europe and neighboring nations. Additionally, the company has also joined forces with the Patient Solutions business unit of Ashfield on a service that will provide clinical educator-led ministering in key areas such as injection training, infusions, and blood pressure monitoring to patients in their own home.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
